ImmunityBio - 53 Year Dividend History | IBRX
Historical dividend payout and yield for ImmunityBio (IBRX) since 1971. The current TTM dividend payout for ImmunityBio (IBRX) as of November 01, 2024 is $0.00. The current dividend yield for ImmunityBio as of November 01, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$3.678B |
$0.001B |
|
ImmunityBio Inc. is a late-clinical-stage immunotherapy company developing therapies which drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems. ImmunityBio Inc., formerly known as NantKwest Inc., is based in CULVER CITY, Calif.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
